Next-gen Flow Cytometry to Find Immune Profiles, Treatment Response, and Toxicity Markers in Skin Cancer Patients Treated With Cemiplimab.

Name: Next-gen Flow Cytometry to Find Immune Profiles, Treatment Response, and Toxicity Markers in Skin Cancer Patients Treated With Cemiplimab.
License: Public Domain

Instituto de Investigación Biomédica de Salamanca

ClinicalTrials.gov · Datasets · License: Public Domain

Open Source ↗

cutaneous squamous cell carcinoma (cscc)

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Record · ID 172326
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.